Role of inducible nitric-oxide synthase in regulation of whole-cell current in lung epithelial cells

J Pharmacol Exp Ther. 2000 Nov;295(2):500-5.

Abstract

Lung inflammation is associated with enhanced expression of proinflammatory cytokines and increased production of nitric oxide (NO) by inducible NO synthase (iNOS). To investigate the possible relationship between cytokine-induced expression of iNOS and epithelial ion channel function, we measured whole-cell current in A549 cells treated with a mixture of cytokines: tumor necrosis factor, interleukin-1 beta, and interferon-gamma for 12 h. Cytokines significantly increased the expression and activity of iNOS, and reduced generation of cGMP in response to stimulation with NO donor S-nitroso-glutathione (GSNO). Patch-clamp studies showed that 100 microM GSNO increased the whole-cell current from 11.2 +/- 1.8 to 19.6 +/- 2.7 pA/pF (n = 16) in control cells, but had no effect in cytokine-treated cells (n = 9). N-(3-(Aminomethyl)benzyl)acetamidine (1400W), a selective inhibitor of iNOS, restored activation of the current by GSNO in cytokine-treated cells, indicating a crucial role for iNOS in this process. Cells treated with cytokines showed increased levels of peroxynitrite (ONOO(-)), compared with the control, or cells that were treated with the cytokines and 1400W or superoxide dismutase/catalase. Treatment of cells with 100 microM ONOO(-) had no effect on the whole-cell current, but in contrast to untreated cells, subsequent application of GSNO did not activate the current. In conclusion, cytokine-induced expression of iNOS affects activation of the whole-cell current via NO/cGMP pathway, likely by increasing the generation of ONOO(-).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cyclic GMP / metabolism
  • Cyclic GMP / pharmacology
  • Cytokines / pharmacology*
  • Enzyme Activation
  • Glutathione / analogs & derivatives*
  • Glutathione / pharmacology
  • Humans
  • Interferon-gamma / pharmacology
  • Interleukin-1 / pharmacology
  • Ion Channels / metabolism
  • Lung / drug effects
  • Lung / enzymology
  • Lung / physiology*
  • Membrane Potentials / drug effects
  • Membrane Potentials / physiology
  • Nitrates / metabolism
  • Nitrates / physiology
  • Nitric Oxide / metabolism
  • Nitric Oxide Donors / pharmacology
  • Nitric Oxide Synthase / antagonists & inhibitors
  • Nitric Oxide Synthase / biosynthesis
  • Nitric Oxide Synthase / metabolism
  • Nitric Oxide Synthase / physiology*
  • Nitric Oxide Synthase Type II
  • Nitric Oxide Synthase Type III
  • Nitroso Compounds / pharmacology
  • Patch-Clamp Techniques
  • Recombinant Proteins
  • S-Nitrosoglutathione
  • Tumor Cells, Cultured
  • Tumor Necrosis Factor-alpha / pharmacology

Substances

  • Cytokines
  • Interleukin-1
  • Ion Channels
  • Nitrates
  • Nitric Oxide Donors
  • Nitroso Compounds
  • Recombinant Proteins
  • Tumor Necrosis Factor-alpha
  • peroxynitric acid
  • Nitric Oxide
  • S-Nitrosoglutathione
  • Interferon-gamma
  • NOS2 protein, human
  • NOS3 protein, human
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type II
  • Nitric Oxide Synthase Type III
  • Glutathione
  • Cyclic GMP